Similarly, studies reported that lymphopenia or absolute lymphocyte count at baseline in patients with glioblastoma were associated with worse overall survival in univariate and multivariate analysis, independent of the extent of resection, IDH mutation status, and adjuvant therapy (51, 52). This evidence concerns the gene IDH1 and glioblastoma.